Peer-reviewed veterinary case report
How Triz-EDTA affects antibiotic resistance of Pseudomonas aeruginosa
By Pye, Charlotte C et al.·Published in Veterinary dermatology·2014·Guelph Veterinary Specialty Hospital, Canada·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Evaluation of the impact of tromethamine edetate disodium dihydrate on antimicrobial susceptibility of Pseudomonas aeruginosa in biofilm in vitro.
- Species:
- dog
Plain-English summary
A group of dogs with chronic ear infections caused by Pseudomonas aeruginosa had their treatment evaluated to see if adding Triz-EDTA (a solution that helps antibiotics work better) would improve the effectiveness of certain antibiotics. The study found that when Triz-EDTA was used alongside gentamicin or neomycin, the antibiotics worked better against the biofilm-embedded bacteria. However, it did not help with polymyxin B, and enrofloxacin actually became less effective. This suggests that using Triz-EDTA could be beneficial for dogs with stubborn ear infections, but more research is needed to confirm these findings.
People also search for: dog ear infection treatment · Pseudomonas otitis in dogs · Triz-EDTA for dog ear infections · gentamicin for dog ear infection · chronic dog ear infection remedies
Abstract
BACKGROUND: Biofilm formation by Pseudomonas aeruginosa has been documented in canine otic isolates. An increase in minimal inhibitory concentration (MIC) for specific antibiotics has been noted for biofilm-embedded bacteria. Tromethamine edetate disodium dihydrate buffered to pH 8 with tromethamine hydrochloride and deionized water (Triz-EDTA(®)) has been documented to potentiate bactericidal activity when used in combination with topical antibiotics, but the impact on biofilm-embedded bacteria is unknown. HYPOTHESIS/OBJECTIVES: The objective of this study was to evaluate the impact of Triz-EDTA(®) use on in vitro antimicrobial susceptibility of biofilm-embedded P. aeruginosa. METHODS: Biofilm formation was documented using a microtitre plate assay. Broth microdilution was used to assess the MIC of neomycin, polymyxin B, enrofloxacin and gentamicin for the biofilm-embedded bacteria. The microtitre plate assay was again used to assess the MIC of neomycin, polymyxin B, enrofloxacin and gentamicin for biofilm-embedded bacteria with added Triz-EDTA(®). RESULTS: Thirty-one isolates from dogs with otitis were tested. Addition of Triz-EDTA(®) significantly reduced MICs for neomycin (P < 0.003) and gentamicin (P < 0.02) but not for polymyxin B (P = 0.3). Enrofloxacin MICs increased in the presence of Triz-EDTA (P < 0.036). CONCLUSIONS AND CLINICAL IMPORTANCE: Triz-EDTA(®) may be a useful adjunctive treatment for chronic cases of Pseudomonas otitis where biofilms may have developed, if gentamicin or neomycin is to be used as a topical treatment. In vivo study is required to confirm this effect.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/24589016/